Analgesia, Patient-Controlled, Arthroscopic Rotator Cuff Repair, Brachial Plexus Block
Conditions
Keywords
Postoperative pain, IV PCA, Continuous interscalene brachial plexus block
Brief summary
The goal of this study is to compare the continuous brachial plexus block with or without intravenous patient controlled analgesia(PCA) in patients undergoing arthroscopic rotator cuff repair, in terms of quality of recovery, postoperative pain score, and adverse event.
Detailed description
The Bellomic® M silicone balloon infuser, dual continuous petite type (cebika, Uiwang-si, Gyeonggi-do, Republic of Korea) has 2-channel infusion elastomeric pump with two balloon chambers. This structure allows the simultaneous use of continuous nerve block and intravenous PCA. In addition, intravenous PCA can be continued even when continuous nerve block is discontinued due to discomfort such as numbness, tingling sense or motor block. This is expected to contribute to the patient satisfaction and quality of recovery.
Interventions
Ultrasonography guided interscalene brachial plexus block was done with a 5 cm block needle and catheter was inserted. (Stimuplex®A, B Braun Medical, Bethlehem, PA). 10 mL 0.375 % ropivacaine was injected through the catheter. 0.2 % ropivacaine 4 ml/hour was injected through the continuous brachial plexus block catheter. IV-PCA with fentanyl (basal flow 0 ml with patient selected bolus 14 mcg, lockout 10 minutes) was started.
Ultrasonography guided interscalene brachial plexus block was done with a 5 cm block needle and catheter was inserted. (Stimuplex®A, B Braun Medical, Bethlehem, PA). 10 mL 0.375 % ropivacaine was injected through the catheter. 0.2 % ropivacaine (4 ml/hour with patient selected bolus 5 ml, lockout 60 minutes) was injected through the continuous brachial plexus block catheter.
Sponsors
Study design
Eligibility
Inclusion criteria
* Having arthroscopic rotator cuff repair * American Society of Anesthesiologists physical status I-III
Exclusion criteria
* Contraindication to interscalene brachial plexus block * Contraindication to fentanyl
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Korean version of the Quality of Recovery-15 questionnaire (QoR-15K) score (0-150, 0: poor recovery, 150: good recovery) | Postoperative 24 hour | Patient recovery measured by QoR-15K score |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain score | Postoperative 6, 24, 48 hour | Numerical Rating Scale (NRS-11(0-10): 0:no Pain and 10:Severe/Worst Pain) |
| Cumulative consumption of PCA and rescue analgesics | Postoperative 24, 48 hour | Cumulative consumption of systemic analgesics |
| Occurrence of adverse effects | Postoperative 24, 48 hour | Nausea, vomiting, numbness, tingling sense, motor and sensory blockade |
Countries
South Korea